More Business Wire
View Older Stories View Newer Stories-
PHINIA Board Declares Quarterly Dividend of $0.30 per Common Share
-
Inocras Announces ASCO 2026 Online Publication: Whole-genome HRD phenotyping as a predictor of PARP inhibitor benefit in first-line maintenance high-grade serous ovarian cancer
-
Align Technology Expands Global Operations With Plans for New Multi-Million Dollar Manufacturing Facility in Hyderabad, India
-
Palladyne AI Announces Employee Equity Awards
-
RCI Receives Anticipated Nasdaq Letter Related to 2Q26 10-Q
-
CoreWeave to Participate in the Jefferies Software, Internet, and AI Conference
-
Domo Updates Timing of First Quarter Fiscal 2027 Earnings Conference Call
-
Accendra Health Announces Offers and Consent Solicitations
-
Bentley Systems, Incorporated Declares Second Quarter 2026 Dividend
-
Salesforce Grants Equity Awards to Cimulate Under Its Inducement Equity Incentive Plan
-
Freebirds’ Slow-Smoked Texas Brisket is Back for a Limited Time
-
CORRECTING and REPLACING QAD | Redzone Expands Collaboration with AWS and TCS to Accelerate AI-Driven Transformation and ERP Modernization
-
GXD Labs and EquitiesFirst Announce Resolution of Claims Relating to Celsius Bankruptcy Estate
-
SPG Launches SPG Learning Hub to Elevate Secure Facility Education Nationwide
-
EDF power solutions North America, Red Rock Indian Band, and Fort William First Nation Announce the Selection of Northern Breeze
-
FDA Grants Accelerated Approval to Gilead’s Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV)
-
Best’s Commentary: Insurers Better Prepared for Rare Disease Outbreak Amid Lessons From COVID-19
-
Balfour Beatty Communities and U.S. Army Fort Gordon Celebrate First New Homes in $50 Million Housing Investment
-
Eurofins Scientific SE: Director/PDMR Shareholding
-
KGS Law Group Recovers Policy Limits in 90% of Cases Without Concessions and Cuts Deposition Prep Time by 96%
-
KBRA Assigns Preliminary Ratings to ByzFunder Asset Securitization I, LLC, Series 2026-1
-
Cleveland-Cliffs Awarded 2025 GM Supplier of the Year by General Motors
-
Oceanhawk Acquisition Corp. Announces Closing of Upsized $160,000,000 Initial Public Offering
-
AM Best Assigns Credit Ratings to Desjardins Financial Security Life Assurance Company
-
CFX and Fitness for Recovery Announce Partnership to Support Recovery Community
-
AM Best to Sponsor and Participate at Latin American Insurance and Reinsurance Seminar in Argentina
-
EPIC Insurance Brokers & Consultants Reports First Rise in Legal Malpractice Claims in Five Years
-
CUPE warns Carney government against unprecedented attack on workers’ rights
-
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch
-
KBRA Assigns Rating to Frontline Insurance Reciprocal Exchange
-
Trecora to Increase Specialty Monomer Prices on Elevated Costs
-
Samsung Strengthens Investment in Canada with Retail Brand Expansion into Three Premier Shopping Destinations
-
Avangrid Foundation Supports Binghamton Philharmonic’s Educational Programming
-
Georgia Tech Wins the Final Year of EcoCAR Challenge
-
For the Seventh Consecutive Year, Hunt Military Communities Earns 2025 SatisFacts Resident Satisfaction Award Company-wide
-
UWMC Urges TWO Stockholders to Stand Firm and Vote AGAINST the CCM Transaction at May 28 Special Meeting
-
CORRECTING and REPLACING Cirion Launches Initial Phase of On-Demand NaaS Connectivity in Latin America with Ciena and Carma
-
Emera Inc. Announces Election of Directors
-
Sinclair Celebrates 110 Years With DINO-Venture, a Nine-City Road Trip Across the West
-
Zelis Recognized as a 2026 Great Place to Work® in the U.S. and India
-
Gotransverse Launches Self-Service Portal to Expand Enterprise Monetization Operations and Customer Account Management
-
HealthNet and AndHealth Celebrate Pharmacy Ribbon Cutting at Barrington Location, Improving Medication Access Across Central Indiana
-
Keller Williams Announces CEO Summit Speakers for Mega Camp 2026
-
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia
-
DATROWAY® (datopotamab deruxtecan-dlnk) approved in the US as first TROP2-directed antibody drug conjugate for 1st-line treatment of patients with metastatic triple-negative breast cancer who are not
-
PharmaEssentia to Present New Clinical Data Supporting the Use of Ropeginterferon Alfa-2b in Essential Thrombocythemia at ASCO and EHA 2026
-
Hunt Capital Partners Announces Grand Opening of Homestead Landing Affordable Housing Community in Price, Utah
-
AM Best Affirms Credit Ratings of Ping An Property & Casualty Insurance Company of China, Ltd
-
ISG to Study UKG Pro Ecosystem Service Providers
-
Datroway® Approved in the U.S. as First TROP2 Directed Antibody Drug Conjugate for First-Line Treatment of Patients with Metastatic Triple Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Cand

